Pharmafrontiers is a biotechnology company developing
autologous cellular therapies to treat several major illnesses,
including multiple sclerosis, cardiovascular disease, and diabetes.
They needed a logo and identity to convey their leadership position
in developing autologous personalized cell therapies for the treatment
of various diseases. Pharmafrontier's focus on its proprietary stem
cell and T-cell technologies for the autologous use of peripheral
blood derived adult stem cells in regenerative medicine lead to
a series of icon studies exploring and breaking down the core message
of the company down to its most basic visual components. The quad-cell
icon was the end result of the process.